Product-Level Documentation
When a documented catalog purity value exists, the product record displays it. Missing analytical data remains explicit rather than being replaced with a generic purity claim.

The compounds in Transcendent Labs are for research by adults only.Confirm you are 18 or older to access.
Bio-Active Engineering © 2026
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous growth hormone (GH) secretion th...

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous growth hormone (GH) secretion through activation of GHRH receptors in the anterior pituitary. The incorporation of the DAC modification allows the peptide to bind to serum albumin, significantly extending its half-life and enabling sustained release and prolonged biological activity compared to non-modified GHRH analogs. This extended activity results in increased pulsatile secretion of growth hormone and subsequent elevation of insulin-like growth factor-1 (IGF-1) levels over an extended period. In research settings, CJC-1295 with DAC has been studied for its role in endocrine regulation, growth hormone dynamics, tissue repair processes, and metabolic function. Its structure is engineered for enhanced stability and resistance to enzymatic degradation, making it a valuable compound for investigating long-acting growth hormone modulation pathways. This product is intended strictly for research purposes only and is not for human consumption, clinical use, or therapeutic application.
Research & documentation
Separate commercial product information from analytical interpretation. Use the research profile, public COA records and method guides to evaluate what is actually documented for this material.
No verified lot-specific public record is linked to this product yet. We show that absence explicitly rather than substitute demo data.
Search COA LibraryUse the purity value and any batch-specific analytical documentation presented for the product as the primary reference. Where available, HPLC, mass spectrometry and Certificate of Analysis documentation provide additional batch context.
Transcendent Labs compounds are supplied strictly for laboratory research use only. They are not intended for human consumption, diagnosis, treatment or therapeutic use.
Inventory status is shown from the current product record. Availability can change as research batches are added, depleted or temporarily disabled in the catalog.
Researchers should follow the compound-specific storage conditions stated in the applicable product documentation or Certificate of Analysis. Batch documentation takes precedence over general handling guidance.
Research quality framework
When a documented catalog purity value exists, the product record displays it. Missing analytical data remains explicit rather than being replaced with a generic purity claim.
The site includes a batch verification workflow designed to connect research inventory with batch-specific documentation when that information is available.
Product positioning, checkout language and catalog documentation consistently identify Transcendent Labs compounds as laboratory research materials only.
Availability is driven by the current product inventory record, helping the public catalog reflect whether a research compound is presently in stock.